Colon cancer: Can GLP-1 drugs help in lowering death rates?

A UC San Diego study reveals GLP-1 receptor agonists, like Ozempic, may significantly reduce colon cancer death rates. Patients using these diabetes and obesity drugs showed dramatically lower five-year mortality, with benefits more pronounced in those with high BMI. Further trials are needed to confirm these promising findings.